Finance

Beta
Lists
532660:BOM
Vivimed Labs Ltd
₹6.26
+1.13%
(+0.070) 1D
Jun 9, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532660...
Open
₹6.19
High
₹6.40
Low
₹6.10
Mkt. cap
522.40M
Avg. vol.
15.10K
Volume
43.00K
52-wk high
₹27.99
52-wk low
₹5.15
EPS
-₹2.93
Shares outstanding
82.52M
No. of employees
586
Open
₹6.19
High
₹6.40
Low
₹6.10
Mkt. cap
522.40M
Avg. vol.
15.10K
Volume
43.00K
52-wk high
₹27.99
52-wk low
₹5.15
EPS
-₹2.93
Shares outstanding
82.52M
No. of employees
586
News stories
From sources across the web
Profile
Vivimed Labs Limited is an India-based global supplier of specialty chemicals and pharmaceuticals. Headquartered in Hyderabad, India. Vivimed is a manufacturer of active pharmaceutical ingredients, active ingredients for home and personal care, hair dyes, imaging chemicals and photochromics. Vivimed Labs operates in 50+ countries and SBUs based in US and Europe along with a marketing office in China. The major areas of concentration are cosmetics, pharmaceuticals, Nutraceuticals, Photochromics, Natural Actives, colors and dyes. Since 2005, Vivimed has acquired James Robinson, UK and Har-Met International Inc.. The company currently has five manufacturing plants located in India along with R&D labs in the UK and India. The company's current slogan is "The Beauty of Chemistry". Wikipedia
About Vivimed Labs Ltd
CEO-
Employees586
Founded1988
HeadquartersHyderabad, Andhra Pradesh, India
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
298.31M
217.66M
208.24M
159.89M
Cost of goods sold
132.11M
97.98M
91.18M
78.98M
Cost of revenue
132.11M
97.98M
91.18M
78.98M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
92.08M
57.05M
55.96M
36.95M
Operating expense
203.16M
168.85M
173.53M
236.41M
Total operating expenses
335.27M
266.83M
264.71M
315.39M
Operating income
-36.96M
-49.17M
-56.47M
-155.50M
Other non operating income
-12.12M
-
10.00K
-
EBT including unusual items
-54.87M
-54.93M
-73.01M
-165.54M
EBT excluding unusual items
-54.87M
-54.93M
-73.01M
-165.54M
Income tax expense
1.13M
-
-
-
Effective tax rate
-2.06%
-
-
-
Other operating expenses
56.08M
61.67M
68.53M
153.18M
Net income
-56.00M
-54.93M
-73.01M
-165.54M
Net profit margin
-18.77%
-25.24%
-35.06%
-103.53%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-5.28M
-5.76M
-16.55M
-10.04M
Net interest expenses
-5.28M
-5.76M
-16.55M
-10.04M
Depreciation and amortization charges
55.00M
50.13M
49.04M
46.28M
EBITDA
13.60M
1.39M
-6.88M
-104.94M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more